{"transactions":[{"id":745844,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-08T22:33:59.000Z","date":"2026-06-08","kind":"grant","planned":false,"acquired":true,"shares":17186,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units issued to the Reporting Person under the Issuer's Amended and Restated 2022 Equity Incentive Plan, which vests on the earlier of June 8, 2027 or the day immediately prior to the Issuer's 2027 Annual Meeting of Stockholders, subject to the Reporting Person's continuing service on the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total number of securities beneficially owned has been adjusted to reflect the Issuer's completion of a 1-for-11 reverse stock split on December 4, 2025."}],"balance_after":20568,"source":{"system":"sec-edgar","filing":"0001104659-26-071475","document":"tm2617186-6_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527710/000110465926071475/tm2617186-6_4seq1.xml","form_type":"4"}},{"id":1097610,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-01T20:02:24.000Z","date":"2025-06-30","kind":"grant","planned":false,"acquired":true,"shares":28147,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units issued to the Reporting Person under the Issuer's Amended and Restated 2022 Equity Incentive Plan, which vests on the earlier of June 30, 2026 or the day immediately prior to the Issuer's 2026 Annual Meeting of Stockholders, subject to the Reporting Person's continuing service on the applicable vesting date."}],"balance_after":37219,"source":{"system":"sec-edgar","filing":"0001104659-25-064710","document":"tm2519510-4_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527710/000110465925064710/tm2519510-4_4seq1.xml","form_type":"4"}},{"id":1486234,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T23:24:16.000Z","date":"2024-06-07","kind":"grant","planned":false,"acquired":true,"shares":5051,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units issued to the Reporting Person under the Issuer's 2022 Equity Incentive Plan, which vests on the earlier of June 7, 2025 or the day immediately prior to the Issuer's 2025 Annual Meeting of Stockholders, subject to the Reporting Person's continuing service on the applicable vesting date."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"The total number of securities beneficially owned\nhas been adjusted to reflect the Issuer's completion\nof a 1-for-8 reverse stock split on December 20,\n2023."}],"balance_after":9072,"source":{"system":"sec-edgar","filing":"0001104659-24-069783","document":"tm2416741-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527710/000110465924069783/tm2416741-1_4seq1.xml","form_type":"4"}},{"id":1723497,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-04T22:12:10.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":7157,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F3","text":"Vests on the earlier of December 1, 2024 or the day prior to the Issuer's next annual meeting of stockholders occurring after the grant date, subject to continuing service."}],"balance_after":32157,"source":{"system":"sec-edgar","filing":"0001527710-23-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527710/000152771023000003/primary_doc.xml","form_type":"4"}},{"id":1723496,"issuer":{"id":7947,"kind":"organization","name":"MetaVia Inc.","symbol":"MTVA"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-04T22:12:10.000Z","date":"2023-12-01","kind":"grant","planned":false,"acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a grant of restricted stock units (\"RSUs\") issued to the reporting person under the Issuer's 2022 Equity Incentive Plan."},{"field":"shares","element":"transactionShares","label":"F2","text":"50% of the RSUs immediately vested on the grant date, and the remainder will vest in two equal installments on each subsequent anniversary of the grant date, subject to continuing service."}],"balance_after":25000,"source":{"system":"sec-edgar","filing":"0001527710-23-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527710/000152771023000003/primary_doc.xml","form_type":"4"}},{"id":2180833,"issuer":{"id":124463,"kind":"organization","name":"Endo International plc","symbol":"ENDP"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP, Global R&D"}}],"security":"2015 Stock Incentive Plan Restricted Stock Units (RSU)","published_at":"2022-08-17T10:31:28.000Z","date":"2022-07-15","kind":"disposition_to_issuer","acquired":false,"shares":280373,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 15, 2022, Dr. Tursi received cash totaling $900,000 in respect of his outstanding RSUs. Upon receipt of this cash payment, the corresponding RSUs were cancelled."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 15, 2022, Dr. Tursi received cash totaling $900,000 in respect of his outstanding RSUs. Upon receipt of this cash payment, the corresponding RSUs were cancelled."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001593034-22-000059","document":"wf-form4_166073227328724.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527710/000159303422000059/wf-form4_166073227328724.xml","form_type":"4"}},{"id":2235695,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2022-06-10T16:45:55.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":807,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option was granted on June 9, 2022 and vests in full on June 9, 2023, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":807,"derivative":{"exercise_price":1.22,"expiration_date":"2032-06-08","underlying":"Common Stock","underlying_shares":807},"source":{"system":"sec-edgar","filing":"0001104659-22-070174","document":"tm2218213-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465922070174/tm2218213-2_4seq1.xml","form_type":"4"}},{"id":2235694,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-10T16:45:55.000Z","date":"2022-06-09","kind":"grant","acquired":true,"shares":670,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units that were granted on June 9, 2022, which will vest and be settled in common stock on June 9, 2023, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On April 26, 2022, the Issuer completed a one-for-forty reverse stock split of the Issuer's common stock. This amount has been adjusted to give effect to this reverse stock split."}],"balance_after":2066,"source":{"system":"sec-edgar","filing":"0001104659-22-070174","document":"tm2218213-2_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465922070174/tm2218213-2_4seq1.xml","form_type":"4"}},{"id":2673682,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-06-10T19:08:31.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":29905,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on June 8, 2021 and vests in full on June 8, 2022, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":29905,"derivative":{"exercise_price":1.53,"expiration_date":"2031-06-07","underlying":"Common Stock","underlying_shares":29905},"source":{"system":"sec-edgar","filing":"0001104659-21-079616","document":"tm2119345-1_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465921079616/tm2119345-1_4seq1.xml","form_type":"4"}},{"id":2673681,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-06-10T19:08:31.000Z","date":"2021-06-08","kind":"grant","acquired":true,"shares":24510,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units that were granted on June 8, 2021, which will vest and be settled in common stock on June 8, 2022, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":55852,"source":{"system":"sec-edgar","filing":"0001104659-21-079616","document":"tm2119345-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465921079616/tm2119345-1_4seq1.xml","form_type":"4"}},{"id":3113190,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2020-06-11T17:22:10.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":22606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on June 9, 2020 and vests in full on June 9, 2021, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":22606,"derivative":{"exercise_price":2.8,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":22606},"source":{"system":"sec-edgar","filing":"0001104659-20-072488","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465920072488/a4.xml","form_type":"4"}},{"id":3113189,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-11T17:22:10.000Z","date":"2020-06-09","kind":"grant","acquired":true,"shares":13393,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These shares represent restricted stock units that were granted on June 9, 2020, which will vest and be settled in common stock on June 9, 2021, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":31342,"source":{"system":"sec-edgar","filing":"0001104659-20-072488","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465920072488/a4.xml","form_type":"4"}},{"id":3490385,"issuer":{"id":126887,"kind":"organization","name":"ANTARES PHARMA, INC.","symbol":"ATRS"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2019-06-14T17:34:37.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":90788,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. Equity Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The options vest and become exercisable in three equal annual installments on the first, second and third anniversaries of the grant date."}],"balance_after":90788,"derivative":{"exercise_price":2.92,"expiration_date":"2029-06-13","underlying":"Common Stock","underlying_shares":90788},"source":{"system":"sec-edgar","filing":"0001209191-19-037223","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1016169/000120919119037223/doc4.xml","form_type":"4"}},{"id":3490384,"issuer":{"id":126887,"kind":"organization","name":"ANTARES PHARMA, INC.","symbol":"ATRS"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-06-14T17:34:37.000Z","date":"2019-06-13","kind":"grant","acquired":true,"shares":45205,"price":2.92,"value":131998.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of restricted stock units made under the Antares Pharma, Inc. Equity Compensation Plan. The shares vest in three equal annual installments from the date of grant."}],"balance_after":45205,"source":{"system":"sec-edgar","filing":"0001209191-19-037223","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016169/000120919119037223/doc4.xml","form_type":"4"}},{"id":3496928,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-06-07T16:32:23.000Z","date":"2019-06-06","kind":"grant","acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 6, 2019 and vests in full on June 6, 2020, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":75000,"derivative":{"exercise_price":1.03,"expiration_date":"2029-06-05","underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001104659-19-034559","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465919034559/a4.xml","form_type":"4"}},{"id":3851082,"issuer":{"id":126887,"kind":"organization","name":"ANTARES PHARMA, INC.","symbol":"ATRS"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Chief Medical Officer"}}],"security":"Stock Option (right to buy)","published_at":"2018-08-07T18:14:43.000Z","date":"2018-08-06","kind":"grant","acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The options vest in equal quarterly installments over three years from the date of grant."}],"balance_after":150000,"derivative":{"exercise_price":2.89,"expiration_date":"2028-08-06","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-18-045755","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1016169/000120919118045755/doc4.xml","form_type":"4"}},{"id":3899772,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-08T17:01:46.000Z","date":"2018-06-08","kind":"exercise","acquired":false,"shares":17949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 8, 2017, the Reporting Person was granted 17,949 restricted stock units, vesting in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attended at least 75% of the board meetings held during the year of board service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 8, 2017, the Reporting Person was granted 17,949 restricted stock units, vesting in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attended at least 75% of the board meetings held during the year of board service."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":17949},"source":{"system":"sec-edgar","filing":"0001104659-18-039217","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465918039217/a4.xml","form_type":"4"}},{"id":3899771,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2018-06-08T17:01:46.000Z","date":"2018-06-07","kind":"grant","acquired":true,"shares":50000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option was granted on June 7, 2018 and vests in full on June 7, 2019, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":50000,"derivative":{"exercise_price":0.6,"expiration_date":"2028-06-06","underlying":"Common Stock","underlying_shares":50000},"source":{"system":"sec-edgar","filing":"0001104659-18-039217","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465918039217/a4.xml","form_type":"4"}},{"id":3899770,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-08T17:01:46.000Z","date":"2018-06-08","kind":"exercise","acquired":true,"shares":17949,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted stock units convert into common stock on a one-for-one basis."}],"balance_after":17949,"source":{"system":"sec-edgar","filing":"0001104659-18-039217","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465918039217/a4.xml","form_type":"4"}},{"id":3930344,"issuer":{"id":165961,"kind":"organization","name":"Aralez Pharmaceuticals Inc.","symbol":"ARLZ"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares, without par value","published_at":"2018-05-16T23:49:56.000Z","date":"2018-05-14","kind":"sale","acquired":false,"shares":9348,"price":0.5222,"value":4881.5256,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 27,730 restricted stock units, which were previously granted on May 11, 2017 and which vested on May 11, 2018."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $0.5206 to $0.5269. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":242052,"source":{"system":"sec-edgar","filing":"0001104659-18-033905","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527710/000110465918033905/a4.xml","form_type":"4"}},{"id":3986114,"issuer":{"id":165961,"kind":"organization","name":"Aralez Pharmaceuticals Inc.","symbol":"ARLZ"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares, without par value","published_at":"2018-03-21T21:16:20.000Z","date":"2018-03-19","kind":"sale","acquired":false,"shares":5950,"price":1.7,"value":10115.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 15,789 restricted stock units, which were previously granted on March 17, 2016 and which vested on March 17, 2018."}],"balance_after":251400,"source":{"system":"sec-edgar","filing":"0001104659-18-019364","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527710/000110465918019364/a4.xml","form_type":"4"}},{"id":4191757,"issuer":{"id":165961,"kind":"organization","name":"Aralez Pharmaceuticals Inc.","symbol":"ARLZ"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares, without par value","published_at":"2017-10-05T00:32:44.000Z","date":"2017-10-02","kind":"sale","acquired":false,"shares":9960,"price":2.5018,"value":24917.928,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This represents shares sold by the issuer on behalf of the reporting person pursuant to an instruction made in accordance with Rule 10b5-1 for payment of withholding tax liability incurred upon the vesting of 29,000 restricted stock units, which vested on October 1, 2017.  7,284 of such restricted stock units were previously granted on October 1, 2015 and 21,716 of such restricted stock units were previously granted on February 12, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $2.50 to $2.51. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":257350,"source":{"system":"sec-edgar","filing":"0001179110-17-013135","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527710/000117911017013135/edgar.xml","form_type":"4"}},{"id":4286846,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-09T17:04:00.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":17949,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units were granted on June 8, 2017 and vest in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units were granted on June 8, 2017 and vest in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":17949,"derivative":{"underlying":"Common Stock","underlying_shares":17949},"source":{"system":"sec-edgar","filing":"0001104659-17-038463","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465917038463/a4.xml","form_type":"4"}},{"id":4286845,"issuer":{"id":87994,"kind":"organization","name":"AGILE THERAPEUTICS INC","symbol":"AGRX"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2017-06-09T17:04:00.000Z","date":"2017-06-08","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option was granted on June 8, 2017 and vests in full on June 8, 2018, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date and provided that the Reporting Person attends at least 75% of the board meetings held during the year of board service."}],"balance_after":14000,"derivative":{"exercise_price":3.9,"expiration_date":"2027-06-07","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001104659-17-038463","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1261249/000110465917038463/a4.xml","form_type":"4"}},{"id":4322273,"issuer":{"id":165961,"kind":"organization","name":"Aralez Pharmaceuticals Inc.","symbol":"ARLZ"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-05-13T01:52:42.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":96121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option vests as to 25% of the shares on May 11, 2018, and the remainder vests in substantially equal monthly installments over the 36 months immediately following such date, subject to continued employment or service to the Company."}],"balance_after":96121,"derivative":{"exercise_price":1.56,"expiration_date":"2027-05-11","underlying":"Common Shares, without par value","underlying_shares":96121},"source":{"system":"sec-edgar","filing":"0001104659-17-032414","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1527710/000110465917032414/a4.xml","form_type":"4"}},{"id":4322272,"issuer":{"id":165961,"kind":"organization","name":"Aralez Pharmaceuticals Inc.","symbol":"ARLZ"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares, without par value","published_at":"2017-05-13T01:52:42.000Z","date":"2017-05-11","kind":"grant","acquired":true,"shares":83192,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted Stock Units granted pursuant to the Aralez Pharmaceuticals Inc. 2016 Amended and Restated Long-Term Incentive Plan, which vest in substantially equal  annual installments over the three years immediately following the date of grant, subject to continued employment or service to the Company."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 65,538 shares of Common Stock and 201,772 Restricted Stock Units."}],"balance_after":267310,"source":{"system":"sec-edgar","filing":"0001104659-17-032414","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527710/000110465917032414/a4.xml","form_type":"4"}},{"id":4379214,"issuer":{"id":165961,"kind":"organization","name":"Aralez Pharmaceuticals Inc.","symbol":"ARLZ"},"owners":[{"id":40395,"kind":"person","name":"Tursi James Patrick","position":1,"cik":"0001527710","reported_name":"Tursi James Patrick","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Shares, without par value","published_at":"2017-03-17T20:16:23.000Z","date":"2017-03-15","kind":"purchase","acquired":true,"shares":4750,"price":2.11,"value":10022.5,"ownership":{"direct":true},"balance_after":184118,"source":{"system":"sec-edgar","filing":"0001104659-17-017605","document":"a4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1527710/000110465917017605/a4.xml","form_type":"4"}}]}